Please login to the form below

Not currently logged in
Email:
Password:

Pharma market

This page shows the latest Pharma market news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca wins NICE backing for asthma injection

AstraZeneca wins NICE backing for asthma injection

NICE hails 'competitive pharma market'. NICE has recommended the use of AstraZeneca’s severe asthma treatment Faserna (benralizumab) after the company revised its initial pricing offer. ... The recommendation from England's cost effectiveness watchdog

Latest news

  • Pharma’s R&D productivity sinks to a new low Pharma’s R&D productivity sinks to a new low

    Returns at their lowest since 2010. Despite 2018 being another strong year for the pharma and biotech sectors, including what looks set to be a record-breaking number of FDA approvals, ... It’s no secret that smaller pharma and biotech firms have been

  • China first market to approve AZ’s kidney drug roxadustat China first market to approve AZ’s kidney drug roxadustat

    China is an important market for the orally-active drug because it has far more CKD patients than the US – some estimates suggest five times as many. ... AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while Astellas

  • D-day: time to make digital deliver D-day: time to make digital deliver

    The development of digital tools and services is not a traditional strength for pharma. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • Roche enters NASH race with deal to buy Jecure Roche enters NASH race with deal to buy Jecure

    Company joins Novartis, Pfizer and others in nascent market. Roche has joined the melee of pharma companies trying to claim a share of the market for non-alcoholic steatohepatitis (NASH) drugs, ... health crisis - and an untapped pharma market.

  • Chi-Med and Lilly’s cancer drug Elunate a milestone for China Chi-Med and Lilly’s cancer drug Elunate a milestone for China

    Chi-Med has achieved a major milestone for itself and China’s fast-developing pharma market, announcing today the launch of cancer treatment Elunate (fruquintinib) in the country. ... The company has ambitions beyond its home market, and wants to

More from news
Approximately 1 fully matching, plus 386 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    When Pharma Market Europe named Susan Galbraith in its list of 30 Women Leaders in UK Healthcare in June this year, Pangalos was quick to credit her role in the renaissance. ... KUDOS had discovered olaparib, the first-in- class PARP inhibitor, which

  • Pharma: in search of the sustainable ‘win win’ with the NHS Pharma: in search of the sustainable ‘win win’ with the NHS

    But how can the pharma industry engage with these new models of care? ... I’ll be chairing Pharma Market Europe and IQVIA’s roundtable next week tackling this central question:.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise. ... and a series of sweeping reforms is now opening China’s pharma market to rapid modernisation.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    So how is pharma trying to repair the damage of yesterday’s behaviours? ... Its success shows what pharma can do when it moves from provider to facilitator.

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    In the regulated world of pharmaceutical marketing,   how can a brand build a meaningful relationship with its customers? This article explores healthcare professionals’ (HCPs) perceptions of pharmaceutical companies, using analysis of online

More from intelligence
Approximately 0 fully matching, plus 95 partially matching documents found.

Latest appointments

  • Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

    Having spent many years working in the pharma industry in sales, market access and business development roles, Matthew has a wealth of knowledge and experience, and he will be a very ... Before joining Janssen Kirby was at Nycomed Pharmaceuticals, where

  • Bayer UK and Ireland appoints new CEO Bayer UK and Ireland appoints new CEO

    was head of the pharma group’s global market access business. ... He said: “Looking in from afar, the progress the UK and Ireland has made over the last four years alone, with the UK becoming the third largest Bayer market in Europe

  • Medmeme bolsters its sales team Medmeme bolsters its sales team

    Mahesh Naithani, founder of Medmeme, said: “Franco is ideally placed to drive sales for Medmeme’s unique offering which can yield transformative and market-differentiating benefits for pharma and other healthcare

  • MRN expands operations with new senior director MRN expands operations with new senior director

    He said: “In my previous role, I was becoming more and more aware and interested in the growing role home healthcare and how it revolutionising both the pharma industry and health ... outcomes. “MRN is the market leader and working with pharma

  • PharmaVentures adds to business development team PharmaVentures adds to business development team

    Combe has over 18 years of experience in business development within the pharma and biotech industries, as well as the media and events sectors. ... Previously, Combe ran his own business, Biosell, which specialised in providing sales and marketing

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 71 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics